These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 36153882)
41. Recurrence of retinal vein thrombosis with Pycnogenol® or Aspirin® supplementation: a registry study. Rodriguez P; Belcaro G; Dugall M; Hu S; Luzzi R; Ledda A; Ippolito E; Corsi M; Ricci A; Feragalli B; Cornelli U; Gizzi C; Hosoi M Panminerva Med; 2015 Sep; 57(3):121-5. PubMed ID: 25971329 [TBL] [Abstract][Full Text] [Related]
42. Pleiotropic Effects of French Maritime Pine Bark Extract to Promote Healthy Aging. Rohdewald P Rejuvenation Res; 2019 Jun; 22(3):210-217. PubMed ID: 30215292 [TBL] [Abstract][Full Text] [Related]
43. Recurrent retinal vein thrombosis: prevention with Aspirin, Pycnogenol®, ticlopidine, or sulodexide. Belcaro G; Dugall M; Bradford HD; Cesarone MR; Feragalli B; Gizzi C; Cotellese R; Hu S; Rodriguez P; Hosoi M Minerva Cardioangiol; 2019 Apr; 67(2):109-114. PubMed ID: 30964246 [TBL] [Abstract][Full Text] [Related]
44. Pycnogenol, French maritime pine bark extract, augments endothelium-dependent vasodilation in humans. Nishioka K; Hidaka T; Nakamura S; Umemura T; Jitsuiki D; Soga J; Goto C; Chayama K; Yoshizumi M; Higashi Y Hypertens Res; 2007 Sep; 30(9):775-80. PubMed ID: 18037769 [TBL] [Abstract][Full Text] [Related]
45. Hangover and fatigue: effects of Robuvit® supplementation. A pilot registry study. Hu S; Belcaro G; Cesarone MR; Scipione C; Scipione V; Hosoi M; Cornelli U; Pellegrini L; Dugall M; Feragalli B; Cotellese R Minerva Cardioangiol; 2020 Jun; 68(3):203-208. PubMed ID: 32586071 [TBL] [Abstract][Full Text] [Related]
46. Long-haul flights, edema, and thrombotic events: prevention with stockings and Pycnogenol® supplementation (LONFLIT Registry Study). Belcaro G; Cornelli U; Dugall M; Hosoi M; Cotellese R; Feragalli B Minerva Cardioangiol; 2018 Apr; 66(2):152-159. PubMed ID: 29512362 [TBL] [Abstract][Full Text] [Related]
47. Pycnogenol® prevents skin hyperpigmentation following sclerotherapy. Cesarone MR; Belcaro G; Cox D; Scipione V; Scipione C; Dugall M; Cornelli U; Hosoi M; Feragalli B; Hu S; Cotellese R Minerva Surg; 2024 Apr; 79(2):161-165. PubMed ID: 38592434 [TBL] [Abstract][Full Text] [Related]
48. Pycnogenol® Supplementation Prevents Recurrent Urinary Tract Infections/Inflammation and Interstitial Cystitis. Ledda A; Hu S; Cesarone MR; Belcaro G; Dugall M; Feragalli B; Cotellese R; Hosoi M; Ippolito E; Corsi M; Luzzi R Evid Based Complement Alternat Med; 2021; 2021():9976299. PubMed ID: 34257695 [TBL] [Abstract][Full Text] [Related]
49. Pycnogenol® (extract of French maritime pine bark) for the treatment of chronic disorders. Schoonees A; Visser J; Musekiwa A; Volmink J Cochrane Database Syst Rev; 2012 Apr; (4):CD008294. PubMed ID: 22513958 [TBL] [Abstract][Full Text] [Related]
50. Pycnogenol® + Centellicum® supplementation improves skin elasticity and microperfusion. Implication for surgical patients: a conceptual registry study. Cotellese R; Belcaro G; Hu S; Cesarone MR; Melchiorre E; Cornelli U; Feragalli B; Scipione C; Scipione V; Dugall M; Hosoi M; Corsi M Minerva Surg; 2024 Sep; ():. PubMed ID: 39259143 [TBL] [Abstract][Full Text] [Related]
51. Treatment of ADHD with French maritime pine bark extract, Pycnogenol. Trebatická J; Kopasová S; Hradecná Z; Cinovský K; Skodácek I; Suba J; Muchová J; Zitnanová I; Waczulíková I; Rohdewald P; Duracková Z Eur Child Adolesc Psychiatry; 2006 Sep; 15(6):329-35. PubMed ID: 16699814 [TBL] [Abstract][Full Text] [Related]
52. Cellular pharmacodynamic effects of Pycnogenol® in patients with severe osteoarthritis: a randomized controlled pilot study. Jessberger S; Högger P; Genest F; Salter DM; Seefried L BMC Complement Altern Med; 2017 Dec; 17(1):537. PubMed ID: 29246219 [TBL] [Abstract][Full Text] [Related]
53. A Clinical Comparison of Pycnogenol, Antistax, and Stocking in Chronic Venous Insufficiency. Belcaro G Int J Angiol; 2015 Dec; 24(4):268-74. PubMed ID: 26648668 [TBL] [Abstract][Full Text] [Related]
54. Chronic venous insufficiency and venous microangiopathy: management with compression and Pycnogenol®. Cesarone MR; Belcaro G; Agus GB; Ippolito E; Dugall M; Hosoi M; Corsi M; Cotellese R; Feragalli B; Scipione C; Scipione V; Maione C Minerva Cardioangiol; 2019 Aug; 67(4):280-287. PubMed ID: 31347820 [TBL] [Abstract][Full Text] [Related]
55. Evaluation of the effects of pycnogenol (French maritime pine bark extract) supplementation on inflammatory biomarkers and nutritional and clinical status in traumatic brain injury patients in an intensive care unit: A randomized clinical trial protocol. Malekahmadi M; Moradi Moghaddam O; Islam SMS; Tanha K; Nematy M; Pahlavani N; Firouzi S; Zali MR; Norouzy A Trials; 2020 Feb; 21(1):162. PubMed ID: 32046747 [TBL] [Abstract][Full Text] [Related]
56. Robuvit® reduces fatigue after chemotherapy for colon cancer. A pilot registry study. Belcaro G; Cox D; Cesarone MR; Scipione C; Scipione V; Dugall M; Hu S; Corsi M; Cornelli U; Feragalli B; Cotellese R; Selvaggi F Minerva Surg; 2023 Aug; 78(4):378-384. PubMed ID: 36995285 [TBL] [Abstract][Full Text] [Related]
57. Effect of low-dose French maritime pine bark extract on climacteric syndrome in 170 perimenopausal women: a randomized, double-blind, placebo-controlled trial. Kohama T; Negami M J Reprod Med; 2013; 58(1-2):39-46. PubMed ID: 23447917 [TBL] [Abstract][Full Text] [Related]
58. Pycnogenol® supplementation improves the control of irritable bowel syndrome symptoms. Belcaro G; Gizzi G; Pellegrini L; Feragalli B; Cotellese R; Cacchio M; Corsi M Panminerva Med; 2018 Jun; 60(2):65-69. PubMed ID: 29737150 [TBL] [Abstract][Full Text] [Related]
59. Oral Pycnogenol® Intake Benefits the Skin in Urban Chinese Outdoor Workers: A Randomized, Placebo-Controlled, Double-Blind, and Crossover Intervention Study. Zhao H; Wu J; Wang N; Grether-Beck S; Krutmann J; Wei L Skin Pharmacol Physiol; 2021; 34(3):135-145. PubMed ID: 33789311 [TBL] [Abstract][Full Text] [Related]